GFT505 | B1030

GFT505 (Elafibranor) is a novel liver-targeted peroxisome proliferator-activated receptor alpha/delta (PPARα/δ) agonist. Displays anti-diabetic effects in db/db mice.

GFT505 (Elafibranor) is a novel liver-targeted peroxisome proliferator-activated receptor alpha/delta (PPARα/δ) agonist. Displays anti-diabetic effects in db/db mice.

B1030 | GFT505 DataSheet

Alternate Name/Synonyms: 2-[2,6-dimethyl-4-[(E)-3-(4-methylsulfanylphenyl)-3-oxoprop-1-enyl]phenoxy]-2-methylpropanoic acid; Elafibranor

Appearance: Crystalline solid

Formulation: N/A

CAS Number: 923978-27-2

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₂H₂₄O₄S

Molecular Weight: 384.39

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO (~ 3 mg/ml)

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A peroxisome proliferator-activated receptor alpha/delta (PPARα/δ) agonist

MDL Number: N/A

PubChem CID: 9864881

SMILES: CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC

InChi: InChI=1S/C22H24O4S/c1-14-12-16(13-15(2)20(14)26-22(3,4)21(24)25)6-11-19(23)17-7-9-18(27-5)10-8-17/h6-13H,1-5H3,(H,24,25)/b11-6+

InChi Key: AFLFKFHDSCQHOL-IZZDOVSWSA-N